{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:58:09Z","timestamp":1791356289191,"version":"4.3.1"},"reference-count":95,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T00:00:00Z","timestamp":1599609600000},"content-version":"vor","delay-in-days":2443,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1194\/jlr.r035964","type":"journal-article","created":{"date-parts":[[2013,3,21]],"date-time":"2013-03-21T00:24:51Z","timestamp":1363825491000},"page":"4-12","source":"Crossref","is-referenced-by-count":74,"title":["HDL and cholesterol: life after the divorce?"],"prefix":"10.1016","volume":"55","author":[{"given":"Kasey C.","family":"Vickers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan T.","family":"Remaley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1194\/jlr.R035964_bib1","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1161\/CIRCULATIONAHA.105.565135","article-title":"Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial","volume":"113","author":"Otvos","year":"2006","journal-title":"Circulation."},{"key":"10.1194\/jlr.R035964_bib2","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ahj.2010.12.007","volume":"161","author":"Tall","year":"2011","journal-title":"Am. Heart J."},{"key":"10.1194\/jlr.R035964_bib3","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy","volume":"365","author":"Boden","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.R035964_bib4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/01.ATV.0000256728.60226.77","article-title":"The failure of torcetrapib: was it the molecule or the mechanism?","volume":"27","author":"Tall","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.R035964_bib5","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.R035964_bib6","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.ahj.2009.09.017","article-title":"Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome","volume":"158","author":"Schwartz","year":"2009","journal-title":"Am. Heart J."},{"key":"10.1194\/jlr.R035964_bib7","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"Effects of dalcetrapib in patients with a recent acute coronary syndrome","volume":"367","author":"Schwartz","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.R035964_bib8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/nrcardio.2011.193","article-title":"Pharmacotherapy: beneficial effects of evacetrapib","volume":"9","author":"Mearns","year":"2012","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1194\/jlr.R035964_bib9","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1001\/jama.2011.1649","article-title":"Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial","volume":"306","author":"Nicholls","year":"2011","journal-title":"JAMA."},{"key":"10.1194\/jlr.R035964_bib10","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.ahj.2011.07.010","article-title":"Efficacy and safety after cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib (MK-0859) in patients with primary hypercholesterolemia or mixed hyperlipidemia","volume":"162","author":"Dansky","year":"2011","journal-title":"Am. Heart J."},{"key":"10.1194\/jlr.R035964_bib11","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1586\/erc.12.82","article-title":"Safety of inhibition of cholesteryl ester transfer protein with anacetrapib: the DEFINE study","volume":"10","author":"Gotto","year":"2012","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"10.1194\/jlr.R035964_bib12","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(12)60312-2","article-title":"Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study","volume":"380","author":"Voight","year":"2012","journal-title":"Lancet."},{"key":"10.1194\/jlr.R035964_bib13","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jacc.2012.03.060","article-title":"High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis)","volume":"60","author":"Mackey","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1194\/jlr.R035964_bib14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","author":"Khera","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.R035964_bib15","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1471-4159.2004.02373.x","article-title":"Uptake and transport of high-density lipoprotein (HDL) and HDL-associated alpha-tocopherol by an in vitro blood-brain barrier model","volume":"89","author":"Balazs","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1194\/jlr.R035964_bib16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/sj.ejcn.1601127","article-title":"Lipophilic antioxidants and polyunsaturated fatty acids in lipoprotein classes: distribution and interaction","volume":"55","author":"Sunesen","year":"2001","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1194\/jlr.R035964_bib17","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/ajcn\/35.4.691","article-title":"Distribution of alpha-tocopherol in human plasma lipoproteins","volume":"35","author":"Behrens","year":"1982","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1194\/jlr.R035964_bib18","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/BF02538909","article-title":"beta-Carotene transport in human lipoproteins. Comparisons with a-tocopherol","volume":"29","author":"Traber","year":"1994","journal-title":"Lipids."},{"key":"10.1194\/jlr.R035964_bib19","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1248\/bpb.32.1131","article-title":"High-density lipoprotein-associated alpha-tocopherol uptake by human retinal pigment epithelial cells (ARPE-19 cells): the irrelevance of scavenger receptor class B, type I","volume":"32","author":"Akanuma","year":"2009","journal-title":"Biol. Pharm. Bull."},{"key":"10.1194\/jlr.R035964_bib20","first-page":"2041","article-title":"Functional involvement of scavenger receptor class B, type I, in the uptake of alpha-tocopherol using cultured rat retinal capillary endothelial cells","volume":"13","author":"Tachikawa","year":"2007","journal-title":"Mol. Vis."},{"key":"10.1194\/jlr.R035964_bib21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1042\/bj3180015","article-title":"Muscle-specific overexpression of lipoprotein lipase in transgenic mice results in increased alpha-tocopherol levels in skeletal muscle","volume":"318","author":"Sattler","year":"1996","journal-title":"Biochem. J."},{"key":"10.1194\/jlr.R035964_bib22","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1172\/JCI26206","article-title":"Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL","volume":"117","author":"Vaisar","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.R035964_bib23","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.bbalip.2011.07.013","article-title":"The HDL proteome in acute coronary syndromes shifts to an inflammatory profile","volume":"1821","author":"Alwaili","year":"2012","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1194\/jlr.R035964_bib24","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bbagen.2007.11.008","article-title":"Differential regulation of apolipoprotein A-I gene expression by vitamin D receptor modulators","volume":"1780","author":"Wehmeier","year":"2008","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1194\/jlr.R035964_bib25","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.nutres.2011.09.005","article-title":"The emerging evidence for vitamin D-mediated regulation of apolipoprotein A-I synthesis","volume":"31","author":"Jaimungal","year":"2011","journal-title":"Nutr. Res."},{"key":"10.1194\/jlr.R035964_bib26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/nu3010063","article-title":"Vitamin A metabolism: an update","volume":"3","author":"D'Ambrosio","year":"2011","journal-title":"Nutrients."},{"key":"10.1194\/jlr.R035964_bib27","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1210\/jcem-68-6-1067","article-title":"Characterization of the binding of thyroxine to high density lipoproteins and apolipoproteins A-I","volume":"68","author":"Benvenga","year":"1989","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1194\/jlr.R035964_bib28","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1089\/thy.1994.4.261","article-title":"Thyroid hormone binding to isolated human apolipoproteins A-II, C\u2013I, C\u2013II, and C\u2013III: homology in thyroxine binding sites","volume":"4","author":"Benvenga","year":"1994","journal-title":"Thyroid."},{"key":"10.1194\/jlr.R035964_bib29","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0008-6363(02)00535-7","article-title":"Lipoprotein-associated estrogens","volume":"56","author":"Tikkanen","year":"2002","journal-title":"Cardiovasc. Res."},{"key":"10.1194\/jlr.R035964_bib30","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.bbalip.2007.08.008","article-title":"High-density lipoprotein-associated 17beta-estradiol fatty acyl ester uptake by Fu5AH hepatoma cells: implications of the roles of scavenger receptor class B, type I and the low-density lipoprotein receptor","volume":"1771","author":"Badeau","year":"2007","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1194\/jlr.R035964_bib31","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1210\/endo.131.3.1505469","article-title":"Elevated levels of endogenous pregnenolone fatty acid esters in follicular fluid high density lipoproteins support progesterone synthesis in porcine granulosa cells","volume":"131","author":"Roy","year":"1992","journal-title":"Endocrinology."},{"key":"10.1194\/jlr.R035964_bib32","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1210\/endo.130.5.1315255","article-title":"Pregnenolone fatty acid esters incorporated into lipoproteins: substrates in adrenal steroidogenesis","volume":"130","author":"Provencher","year":"1992","journal-title":"Endocrinology."},{"key":"10.1194\/jlr.R035964_bib33","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/0006-291X(91)91753-Y","article-title":"Lipoprotein-incorporated pregnenolone fatty acid esters act as substrate for ovarian progestin synthesis","volume":"179","author":"Roy","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1194\/jlr.R035964_bib34","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.tips.2009.08.001","article-title":"Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders","volume":"30","author":"Fiorucci","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1194\/jlr.R035964_bib35","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/S0022-2275(20)35729-1","article-title":"Comparative binding of bile acids to serum lipoproteins and albumin","volume":"34","author":"Ceryak","year":"1993","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.R035964_bib36","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1080\/00365519209115502","article-title":"Serum concentrations and excretion of bile acids in cirrhosis","volume":"52","author":"Jonsson","year":"1992","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1194\/jlr.R035964_bib37","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3109\/00365527709181679","article-title":"Bile acid concentrations in systemic and portal serum in presumably normal man and in cholestatic and cirrhotic conditions","volume":"12","author":"Lindblad","year":"1977","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1194\/jlr.R035964_bib38","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1056\/NEJM197406202902503","article-title":"Assessment of activity in chronic active liver disease. Serum bile acids compared with conventional tests and histology","volume":"290","author":"Korman","year":"1974","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.R035964_bib39","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1042\/CS20110482","article-title":"Lipoprotein distribution and serum concentrations of 7alpha-hydroxy-4-cholesten-3-one and bile acids: effects of monogenic disturbances in high-density lipoprotein metabolism","volume":"122","author":"Steiner","year":"2012","journal-title":"Clin. Sci."},{"key":"10.1194\/jlr.R035964_bib40","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/0005-2760(95)00075-N","article-title":"Identification of the bile acid binding proteins in human serum by photoaffinity labeling","volume":"1257","author":"Kramer","year":"1995","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1194\/jlr.R035964_bib41","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/00365527909179882","article-title":"A bile-acid-rich high-density lipoprotein (HDL) in acute hepatitis","volume":"14","author":"Middelhoff","year":"1979","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1194\/jlr.R035964_bib42","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3109\/00365518609084046","article-title":"Bile acid transport by serum lipoproteins in patients with extrahepatic cholestasis","volume":"46","author":"Hedenborg","year":"1986","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1194\/jlr.R035964_bib43","article-title":"Carotenoids in Health and Disease","author":"Krinsky","year":"2004","journal-title":"CRC Press."},{"key":"10.1194\/jlr.R035964_bib44","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1002\/ijc.22111","article-title":"Beta-cryptoxanthin suppresses the growth of immortalized human bronchial epithelial cells and non-small-cell lung cancer cells and up-regulates retinoic acid receptor beta expression","volume":"119","author":"Lian","year":"2006","journal-title":"Int. J. Cancer."},{"key":"10.1194\/jlr.R035964_bib45","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1172\/JCI118256","article-title":"Beta-carotene inhibits atherosclerosis in hypercholesterolemic rabbits","volume":"96","author":"Shaish","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.R035964_bib46","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1007\/BF00226846","article-title":"Ubiquinone and alpha-tocopherol in plasma: means of translocation or depot","volume":"71","author":"Karlsson","year":"1993","journal-title":"Clin. Investig."},{"key":"10.1194\/jlr.R035964_bib47","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1039\/c2mb25115a","article-title":"Metabolomic analysis of polar metabolites in lipoprotein fractions identifies lipoprotein-specific metabolic profiles and their association with insulin resistance","volume":"8","author":"Hyotylainen","year":"2012","journal-title":"Mol. Biosyst."},{"key":"10.1194\/jlr.R035964_bib48","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1567-5688(02)00045-4","article-title":"Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase","volume":"3","author":"Tselepis","year":"2002","journal-title":"Atheroscler. Suppl."},{"key":"10.1194\/jlr.R035964_bib49","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0891-5849(92)90027-E","article-title":"Free radicals promote modifications in plasma high-density lipoprotein: nuclear magnetic resonance analysis","volume":"12","author":"Bradamante","year":"1992","journal-title":"Free Radic. Biol. Med."},{"key":"10.1194\/jlr.R035964_bib50","doi-asserted-by":"crossref","first-page":"13775","DOI":"10.1074\/jbc.M212262200","article-title":"Biochemical properties of mammalian neutral sphingomyelinase 2 and its role in sphingolipid metabolism","volume":"278","author":"Marchesini","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R035964_bib51","doi-asserted-by":"crossref","first-page":"34480","DOI":"10.1074\/jbc.M103782200","article-title":"Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids","volume":"276","author":"Nofer","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R035964_bib52","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1161\/01.RES.0000225982.01988.93","article-title":"Endothelial and antithrombotic actions of HDL","volume":"98","author":"Mineo","year":"2006","journal-title":"Circ. Res."},{"key":"10.1194\/jlr.R035964_bib53","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1161\/01.ATV.0000079011.67194.5A","article-title":"High-density lipoprotein stimulates endothelial cell migration and survival through sphingosine 1-phosphate and its receptors","volume":"23","author":"Kimura","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.R035964_bib54","doi-asserted-by":"crossref","first-page":"37457","DOI":"10.1074\/jbc.M605823200","article-title":"Role of scavenger receptor class B type I and sphingosine 1-phosphate receptors in high density lipoprotein-induced inhibition of adhesion molecule expression in endothelial cells","volume":"281","author":"Kimura","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R035964_bib55","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1172\/JCI200418004","article-title":"HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3","volume":"113","author":"Nofer","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.R035964_bib56","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/cvr\/cvp137","article-title":"Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion","volume":"83","author":"Hofmann","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1194\/jlr.R035964_bib57","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1161\/01.ATV.0000254679.42583.88","article-title":"The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice","volume":"27","author":"Keul","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.R035964_bib58","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/FJC.0b013e3181926706","article-title":"Sphingosine kinase and sphingosine 1-phosphate in cardioprotection","volume":"53","author":"Karliner","year":"2009","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1194\/jlr.R035964_bib59","first-page":"601","article-title":"Cardioprotective role of sphingosine-1-phosphate","volume":"62","author":"Knapp","year":"2011","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1194\/jlr.R035964_bib60","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/nsmb.2028","article-title":"Apolipoprotein A-I structural organization in high-density lipoproteins isolated from human plasma","volume":"18","author":"Huang","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1194\/jlr.R035964_bib61","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1007\/s00018-005-5125-0","article-title":"Tangier disease: still more questions than answers","volume":"62","author":"Nofer","year":"2005","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1194\/jlr.R035964_bib62","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1161\/01.ATV.17.10.2158","article-title":"HDL and ApoA prevent cell death of endothelial cells induced by oxidized LDL","volume":"17","author":"Suc","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.R035964_bib63","doi-asserted-by":"crossref","first-page":"32336","DOI":"10.1074\/jbc.M109.047472","article-title":"The macrophage cholesterol exporter ABCA1 functions as an anti-inflammatory receptor","volume":"284","author":"Tang","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R035964_bib64","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.atherosclerosis.2010.05.035","article-title":"Anti-inflammatory effects of apolipoprotein A-I in the rabbit","volume":"212","author":"Patel","year":"2010","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.R035964_bib65","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1161\/ATVBAHA.109.201715","article-title":"Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-I","volume":"30","author":"Nobecourt","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.R035964_bib66","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/ATVBAHA.108.168690","article-title":"High-density lipoprotein reduces the human monocyte inflammatory response","volume":"28","author":"Murphy","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.R035964_bib67","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1161\/ATVBAHA.111.226258","article-title":"Neutrophil activation is attenuated by high-density lipoprotein and apolipoprotein A-I in in vitro and in vivo models of inflammation","volume":"31","author":"Murphy","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.R035964_bib68","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.bbrc.2005.10.065","article-title":"Apolipoprotein A-I induces IL-10 and PGE2 production in human monocytes and inhibits dendritic cell differentiation and maturation","volume":"338","author":"Kim","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1194\/jlr.R035964_bib69","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1582-4934.2010.01045.x","article-title":"Apolipoprotein A-I possesses an anti-obesity effect associated with increase of energy expenditure and up-regulation of UCP1 in brown fat","volume":"15","author":"Ruan","year":"2011","journal-title":"J. Cell. Mol. Med."},{"key":"10.1194\/jlr.R035964_bib70","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2174\/157016112800812755","article-title":"Proteomics investigations of HDL: challenges and promise","volume":"10","author":"Vaisar","year":"2012","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1194\/jlr.R035964_bib71","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.bbrc.2005.12.098","article-title":"Diverse range of small peptides associated with high-density lipoprotein","volume":"340","author":"Hortin","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1194\/jlr.R035964_bib72","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/art.34363","article-title":"Proteomic profiling following immunoaffinity capture of high-density lipoprotein: association of acute-phase proteins and complement factors with proinflammatory high-density lipoprotein in rheumatoid arthritis","volume":"64","author":"Watanabe","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1194\/jlr.R035964_bib73","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2010111144","article-title":"Uremia alters HDL composition and function","volume":"22","author":"Holzer","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1194\/jlr.R035964_bib74","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1477-5956-9-34","article-title":"High-density lipoprotein proteome dynamics in human endotoxemia","volume":"9","author":"Levels","year":"2011","journal-title":"Proteome Sci."},{"key":"10.1194\/jlr.R035964_bib75","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.steroids.2012.01.002","article-title":"Acute sex steroid withdrawal increases cholesterol efflux capacity and HDL-associated clusterin in men","volume":"77","author":"Rubinow","year":"2012","journal-title":"Steroids."},{"key":"10.1194\/jlr.R035964_bib76","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.cca.2010.03.023","article-title":"HDL in humans with cardiovascular disease exhibits a proteomic signature","volume":"411","author":"Vaisar","year":"2010","journal-title":"Clin. Chim. Acta."},{"issue":"Suppl","key":"10.1194\/jlr.R035964_bib77","doi-asserted-by":"crossref","first-page":"S167","DOI":"10.1194\/jlr.R800097-JLR200","article-title":"The HDL proteome: a marker - and perhaps mediator - of coronary artery disease","volume":"50","author":"Heinecke","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.R035964_bib78","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/ATVBAHA.108.179317","article-title":"Proteomics of apolipoproteins and associated proteins from plasma high-density lipoproteins","volume":"30","author":"Davidsson","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.R035964_bib79","doi-asserted-by":"crossref","first-page":"e34107","DOI":"10.1371\/journal.pone.0034107","article-title":"HDL proteome in hemodialysis patients: a quantitative nanoflow liquid chromatography-tandem mass spectrometry approach","volume":"7","author":"Mange","year":"2012","journal-title":"PLoS ONE."},{"key":"10.1194\/jlr.R035964_bib80","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1194\/jlr.P026005","article-title":"Testosterone replacement in hypogonadal men alters the HDL proteome but not HDL cholesterol efflux capacity","volume":"53","author":"Rubinow","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.R035964_bib81","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1476-511X-11-116","article-title":"Beneficial effects of omega-3 fatty acids in the proteome of high-density lipoprotein proteome","volume":"11","author":"Burillo","year":"2012","journal-title":"Lipids Health Dis."},{"key":"10.1194\/jlr.R035964_bib82","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1161\/CIRCULATIONAHA.108.770669","article-title":"Combined statin and niacin therapy remodels the high-density lipoprotein proteome","volume":"118","author":"Green","year":"2008","journal-title":"Circulation."},{"key":"10.1194\/jlr.R035964_bib83","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1096\/fj.08-127928","article-title":"HDL antielastase activity prevents smooth muscle cell anoikis, a potential new antiatherogenic property","volume":"23","author":"Ortiz-Munoz","year":"2009","journal-title":"FASEB J."},{"key":"10.1194\/jlr.R035964_bib84","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1172\/JCI1649","article-title":"Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase","volume":"101","author":"Aviram","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.R035964_bib85","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.2174\/138161210791051013","article-title":"High-density lipoprotein-mediated anti-atherosclerotic and endothelial-protective effects: a potential novel therapeutic target in cardiovascular disease","volume":"16","author":"Besler","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1194\/jlr.R035964_bib86","doi-asserted-by":"crossref","first-page":"18292","DOI":"10.1074\/jbc.M109.017202","article-title":"Hemoglobin and its scavenger protein haptoglobin associate with apoA-1-containing particles and influence the inflammatory properties and function of high density lipoprotein","volume":"284","author":"Watanabe","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.R035964_bib87","doi-asserted-by":"crossref","first-page":"15454","DOI":"10.1073\/pnas.0813216106","article-title":"Unexpected expression of alpha- and beta-globin in mesencephalic dopaminergic neurons and glial cells","volume":"106","author":"Biagioli","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.R035964_bib88","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/ncb2210","article-title":"MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins","volume":"13","author":"Vickers","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1194\/jlr.R035964_bib89","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/MOL.0b013e328350a425","article-title":"Lipid-based carriers of microRNAs and intercellular communication","volume":"23","author":"Vickers","year":"2012","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1194\/jlr.R035964_bib90","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1101\/gad.1837609","article-title":"A novel class of small RNAs: tRNA-derived RNA fragments (tRFs)","volume":"23","author":"Lee","year":"2009","journal-title":"Genes Dev."},{"key":"10.1194\/jlr.R035964_bib91","doi-asserted-by":"crossref","first-page":"6787","DOI":"10.1093\/nar\/gks307","article-title":"Extensive terminal and asymmetric processing of small RNAs from rRNAs, snoRNAs, snRNAs, and tRNAs","volume":"40","author":"Li","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1194\/jlr.R035964_bib92","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1261\/rna.2000810","article-title":"Human tRNA-derived small RNAs in the global regulation of RNA silencing","volume":"16","author":"Haussecker","year":"2010","journal-title":"RNA."},{"key":"10.1194\/jlr.R035964_bib93","doi-asserted-by":"crossref","first-page":"573","DOI":"10.4161\/rna.7.5.13141","article-title":"A miRNA-tRNA mix-up: tRNA origin of proposed miRNA","volume":"7","author":"Schopman","year":"2010","journal-title":"RNA Biol."},{"key":"10.1194\/jlr.R035964_bib94","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bbrc.2012.11.005","article-title":"SnoN\/SKIL modulates proliferation through control of hsa-miR-720 transcription in esophageal cancer cells","volume":"430","author":"Shinozuka","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1194\/jlr.R035964_bib95","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.molmed.2011.05.013","article-title":"Biological activities of HDL subpopulations and their relevance to cardiovascular disease","volume":"17","author":"Camont","year":"2011","journal-title":"Trends Mol. Med."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520317375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520317375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1194\/jlr.R035964","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T16:05:44Z","timestamp":1637424344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227520317375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0022227520317375"],"URL":"https:\/\/doi.org\/10.1194\/jlr.r035964","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}